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Protein clearing pathways named autophagy (ATG) and ubiquitin proteasome
(UP) control homeostasis within eukaryotic cells, while their dysfunction produces
neurodegeneration. These pathways are viewed as distinct biochemical cascades
occurring within specific cytosolic compartments owing pathway-specific enzymatic
activity. Recent data strongly challenged the concept of two morphologically
distinct and functionally segregated compartments. In fact, preliminary evidence
suggests the convergence of these pathways to form a novel organelle named
autophagoproteasome. This is characterized in the present study by using a cell line
where, mTOR activity is upregulated and autophagy is suppressed. This was reversed
dose-dependently by administering the mTOR inhibitor rapamycin. Thus, we could
study autophagoproteasomes when autophagy was either suppressed or stimulated.
The occurrence of autophagoproteasome was shown also in non-human cell lines.
Ultrastructural morphometry, based on the stochiometric binding of immunogold
particles allowed the quantitative evaluation of ATG and UP component within
autophagoproteasomes. The number of autophagoproteasomes increases following
mTOR inhibition. Similarly, mTOR inhibition produces overexpression of both LC3 and
P20S particles. This is confirmed by the fact that the ratio of free vs. autophagosome-
bound LC3 is similar to that measured for P20S, both in baseline conditions and
following mTOR inhibition. Remarkably, within autophagoproteasomes there is a slight
prevalence of ATG compared with UP components for low rapamycin doses, whereas
for higher rapamycin doses UP increases more than ATG. While LC3 is widely present
within cytosol, UP is strongly polarized within autophagoproteasomes. These fine details
were evident at electron microscopy but could not be deciphered by using confocal
microscopy. Despite its morphological novelty autophagoproteasomes appear in the
natural site where clearing pathways (once believed to be anatomically segregated)
co-exist and they are likely to interact at molecular level. In fact, LC3 and P20S co-
immunoprecipitate, suggesting a specific binding and functional interplay, which may
be altered by inhibiting mTOR. In summary, ATG and UP often represent two facets
of a single organelle, in which unexpected amount of enzymatic activity should be
available. Thus, autophagoproteasome may represent a sophisticated ultimate clearing
apparatus.
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INTRODUCTION
Recently, we described that clearing systems such as the
Ubiquitine Proteasome (UP) and Autophagy (ATG) may
occur within single morphological entities we named
autophagoproteasome (Isidoro et al., 2009; Pasquali et al.,
2009; Ferrucci et al., 2011; Natale et al., 2011; Klionsky
et al., 2016). Our research team described this organelle in
the last decade starting from serendipitous findings, which
suggested the expression of both ATG and UP antigens within
similar morphological compartments (Castino et al., 2008).
At present, when contributing to the ‘‘Guidelines for the use
and interpretation of assays for monitoring autophagy’’ (3rd
edition) by Klionsky et al. (2016) we shared the definition
of autophagoproteasome as ‘‘A cytosolic membrane-bound
compartment denoted by a limiting single, double or multiple
membrane, which contains both LC3 and UP antigens’’
(Klionsky et al., 2016). When writing the autophagy glossary
in the guidelines we contributed to the hypothesis that ‘‘The
autophagoproteasome may be derived from the inclusion
of ubiquitin-proteasome structures within either early or
late autophagosomes containing cytoplasmic material at
various stages of degradation’’ (Klionsky et al., 2016). This
was based on recent unpublished data. In fact, despite we
coined the term autophagoproteasome in the last decade
(Pasquali et al., 2009), no specific study was designed to
characterize in depth such an organelle. This is crucial
since biomedical research is producing increasing evidence
on the seminal role played by all clearing pathways in
modulating cell survival and disease mechanisms. In fact,
ATG and/or UP are involved in a wide range of disorders
encompassing tumors (Liang et al., 1999; Qu et al., 2003;
Mani and Gelmann, 2005; Bazzaro et al., 2006; Takamura
et al., 2011; Huang and Dixit, 2016; Liu and Debnath,
2016), cardiovascular diseases (Nakai et al., 2007; Willis
and Patterson, 2013; Wang and Robbins, 2014; Willis et al.,
2014; Delbridge et al., 2015), and neurodegenerative disorders
(Nedelsky et al., 2008; Bedford et al., 2009; Chu et al., 2009;
Madeo et al., 2009; Dantuma and Bott, 2014; Menzies et al.,
2015).
The classic definition which is used so far considers
these cell clearing pathways to possess distinct biochemical
activities which take place within different ultrastructural
compartments of eukaryotic cells. In fact, the classic ATG
pathway occurs within a double-layered cytosolic vacuole
named autophagosome which merges with lysosomes to
produce an autophagolysosome which is gifted with a rich
enzymatic apparatus to clear various cell cargoes (Klionsky
et al., 2016, for a comprehensive definition). In contrast,
the classic UP pathway does not imply a well-defined cell
organelle. The UP activity is rather considered to occur
within dispersed cytosolic domains where UP components
represented by two 19S (PA700) subunits and one P20S
subunit interact to recognize altered ubiquitinated substrates
to provide specific proteolytic clearance (Ciechanover et al.,
1981; Hershko et al., 1981; Fornai et al., 2003; Ciechanover,
2006, 2015). In keeping with this, a considerable amount of
research studies compared the specificity of each compartment
in providing the clearance of specific substrates. Thus, ATG
and UP may be further characterized by distinct substrate
specificity. In summary, the classic view considers these
clearing pathways as distinct depending on various items:
compartmentalization, substrate-specificity, enzymatic activities,
roles in cell homeostasis.
This manuscript is aimed at characterizing a morpho-
functional entity where UP and ATG takes place, which is
named autophagoproteasome. The studies are carried out both
in baseline conditions and following dose-dependent mTOR
inhibition induced by rapamycin. The specimens used to
carry out this analysis derive from a variety of experiments
from the past 15 years which were implemented by very
recent data.
Old specimens were further analyzed to detail and improve
early light and electron microscopy data which suggested the
occurrence of autophagoproteasome (Fornai et al., 2004; Lazzeri
et al., 2007; Ferrucci et al., 2008, 2011; Pasquali et al., 2008; Lenzi
et al., 2012).
Additional experiments were carried out by using confocal
microscopy, immmuno-electron microscopy and quantitative
morphometry to measure the amount of autophagoproteasomes
compared with pure UP or ATG components. All the data
reported here were originally generated by the authors of the
present manuscript when providing early electron microscopy
evidence.
To remark the natural occurrence of autophagoproteasomes
even when ATGmachinery was depressed a series of experiments
was carried out in glioblastoma cell lines (U87MG). In fact
these eukariotic cells possess a weak ATG machinery which
is due to the up-regulation of mTOR (Jiang et al., 2009; Fan
and Weiss, 2012; Arcella et al., 2013; Catalano et al., 2015).
In these cells we produced a dose-dependent recovery of ATG
activity which shifted from down- to up-regulation under the
effects of increasing doses of the mTOR inhibitor rapamycin.
This was planned to understand the relationship between
autophagoproteasomes and the level of mTOR inhibition/ATG
activation.
In fact, if the autophagoproteasome represents a solid reality,
then one should expect it to occur even when ATG activity
is weak. Again, if the occurrence of autophagoproteasomes
is related to ATG activity, then one would expect that
recovery of ATG activity under a gold-standard ATG activator
(rapamycin) should lead to an increase in the number of
autophagoproteasomes.
Since these experiments demonstrate a remarkable merging
between ATG and UP components within the very same
autophagoproteasomes, further experiments were designed to
assess the potential occurrence of molecular binding between
UP and ATG components. Therefore, we carried out co-
immunoprecipitation experiments, both in baseline conditions
and following rapamycin. This inaugural article is aimed to
provide functional and morphological evidence for a novel
anatomical organelle, which is likely to be key in understanding
neuronal (and cell) metabolism and in neurobiology of
disease.
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MATERIALS AND METHODS
Cell Lines
The human glioblastoma cell lines U87MG (grade-IV), were
obtained from Cell Bank (IRCC San Martino-IST, Genova).
U87MG were maintained in DMEM medium (Sigma, Italy)
supplemented with 10% Fetal bovine serum (FBS; Sigma, Italy),
1% of MEM non-essential amino-acid (MEM-NEAA), penicillin
(50 IU/mL), and 100µg streptomycin. Cell lines weremaintained
at 37◦C in a humidified atmosphere containing 5% CO2 and the
medium was renewed 2–3 times per week. at 37◦C, 5% CO2 and
95% of humidity. For transmission electron microscopy (TEM)
1 × 106 cells were seeded in 6-well plates in a final volume of
2 ml/well. For confocal light microscopy 5 × 102 U87MG cells
were seeded on cover slips in 24-well plates in a final volume of
1 ml/well while PC12 cells were seeded at a density of 3 × 104
cells in a 24-well plates in culture medium (2 ml/well). After 24 h
at 37◦C in 5% CO2, both cell lines were treated with rapamycin
(1, 10, 100 and 1000 nM for 24 h). Dilutions of rapamycin
were obtained by a stock solution (1 µM of rapamycin dissolved
in culture medium containing 10% DMSO). Control cells were
maintained in culture medium containing 0.01% DMSO.
Additional data were produced in rat PC12 cell line to
document the species-independency of autophagoproteasome.
PC12 Cell line was obtained from the Cell Bank (IRCC San
Martino-IST, Genova). The cells were grown in RPMI 1640
medium supplemented with 10% heat-inactivated horse serum,
5% FBS, penicillin (50 IU/mL), and streptomycin (50 mg/mL).
Cells were maintained at 37◦C in a humidified atmosphere
containing 5% CO2 and the medium was renewed 2–3 times
per week. U87MG and PC12 cells were similarly processed for
morphometry.
Confocal Microscopy
Cells were washed in phosphate-buffered saline (PBS) and fixed
with methanol at room temperature for 5 min. Antigen retrieval
was performed in 100 mM TrisHCl, 5% urea at 95◦C for 10 min.
After washing in PBS, cells were permeabilized in 0.2% Triton X-
100 for 10 min and then blocked in PBST (PBS + 0.1% Tween-
20), supplemented with 1% bovine serum albumin (BSA) and
22.52 mg/ml of glycine, for 30 min. Cells were then incubated
overnight at 4◦C in 1% BSA in PBST containing 1:50 anti-LC3
antibody (Abcam, Cambridge, UK) and 1:15 anti-P20S (Abcam,
Cambridge, UK). After extensive washes in PBST, cells were
incubated for 1 h at room temperature with a 1:200 dilution of
appropriate fluorophore-conjugated secondary antibodies (goat
anti-rabbit Alexa 488 and goat anti-mouse Alexa 594, Molecular
Probes, Life Technologies) in 1% BSA in PBST. Cells were then
washed in PBS and mounted in Prolong Diamond Antifade
Mountant (Molecular Probes, Life Technologies). The analysis
was performed using a Leica TCS SP5 confocal laser-scanning
microscope (Leica Microsystems, Mannheim, Germany) using a
sequential scan procedure. Confocal images were collected every
400 nm intervals through the z-axis of sections by means of 63×
oil lenses. Z-stacks of serial optical planes were analyzed using
the Multicolor Package software (Leica Microsystems). Negative
controls were performed, omitting the primary antibodies.
Co-Immunoprecipitation Assay
U87MG cells were homogenized at 4◦C in ice-cold lysis
buffer. One microliter of homogenates was used for protein
determinations. Proteins (600 µg) were incubated at 4◦C
overnight with primary rabbit anti-LC3 antibody (3 µg for
each sample; Sigma Aldrich, Milan, Italy). The antibody/antigen
complex was pulled out of the sample using protein A-sepharose
beads. This process isolated the protein of interest from
the rest of the sample. Proteins were separated on sodium
dodecyl sulfate polyacrylamide gel (15%) and transferred on
Immuno-polyvinylidene difluoride (PVDF) membrane (Biorad,
Milan, Italy) for 1 h. Filter was blocked for 1 h in Tween-
20 Tris-buffered saline (TTBS; 100 mM Tris-HCl, 0.9% NaCl,
1% Tween 20, pH 7.4) containing 5% non-fat dry milk.
Blot was incubated at 4◦C overnight with primary antibody
mouse monoclonal anti-Proteasome 20S (1:100, Abcam); it
was washed three times with TTBS buffer and then incubated
for 1 h with secondary peroxidase-coupled antibody (anti-
mouse, 1:7000; Calbiochem, Milan, Italy). Then blot was
incubated with primary rabbit anti-LC3B antibody (1:6000,
Sigma Aldrich) for 1 h at room temperature. Finally, filter
was washed three times with TTBS buffer and then it was
incubated for 1 h with secondary peroxidase-coupled antibody
(anti-rabbit, 1:7000; Calbiochem, Milan, Italy). Immunostaining
was revealed by enhanced chemoluminescence (GE Healthcare,
Milan, Italy).
Transmission Electron Microscopy
U87MG cells were centrifuged at 1000 g for 5 min. After
removal of the supernatant, pellet was thoroughly rinsed in
PBS. Fixation was carried out with a solution containing 2.0%
paraformaldehyde/0.1% glutaraldehyde in 0.1 M PBS (pH 7.4)
for 90 min at 4◦C. This procedure was validated by previous
studies as the best fixing procedure for immunocytochemistry
when studying autophagy vacuoles. In fact, this fixing solution
allows a minimal cover of antigen epitopes preserving the
morphology of the tissue. Moreover, this method prevents the
occurrence of specific TEM artifacts due to high aldehydes
concentrations, which could impair the detection of authentic
autophagy vacuoles (Fornai et al., 2001). Specimens were post-
fixed in 1% OsO4 for 1 h at 4◦C; they were dehydrated in ethanol
and embedded in Epoxy-resin.
For ultrastructural morphometry, sections were examined
directly at TEM at a magnification of 8000×. Each grid contained
non-serial sections to count at least 10 cells.
Several grids were observed in order to obtain a total number
of at least 50 cells for each experimental group. This number
was obtained by sampling cells from at least three experiments.
Data obtained in this series of experiments were overlapping
those previously measured along the last decade in about 15 pilot
studies.
Details on Post-Embedding Procedure
Specimens were post-fixed in 1% OsO4 for 1 h at 4◦C
and then they were dehydrated in ethanol and embedded in
epoxy resin. Ultrathin sections (40–50 nm) of U87MG were
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cut at ultramicrotome. Similarly to fixing, post-fixing and
embedding procedures were validated on pilot studies and they
were reported by current literature as optimal conditions for
immunogold-based ultrastructural morphometry. We avoided
routine method, which consists in avoiding osmium post-fixing
and embedding specimens in acrylic resins after fixing with
aldehydes only. In fact, such a procedure despite preserving
epitopes impairs the preservation of the finest sub-cellular
architecture. The method employed here, which combines
aldehyde and mild OsO4 as first and second fixing steps allows
minimal epitope covering while preserving cell architecture
and providing an optimal ‘‘contrast effect’’ of various cell
compartments. This method allows preserving sub-cellular
structures with acceptable epitope integrity (Bendayan and
Zollinger, 1983; D’Alessandro et al., 2004).
In fact, osmium enhances the contrast of various cytosolic
compartments by marking membranes phospholipids, as clearly
confirmed by Swanlund in describing the gold standard of TEM
procedures in studying autophagy (Swanlund et al., 2010). Again,
the binding of osmium to cell membranes prevents the formation
of membranous artifacts, which may mimic ATG vacuoles.
Post-fixed samples were then embedded using epoxy resin.
We used epoxy resin, instead of acrylic resin such as LR White,
since it is well-established and commonly used as embedding
media for TEM, allowing an optimal ultrastructural resolution.
The post-embedding was carried out collecting ultrathin
sections on nickel grids and incubating them in aqueous
saturated sodium metaperiodate (NaIO4) for roughly 30 min
at room temperature in order to remove OsO4 from the
samples. After washing with PBS pH 7.4, ultrathin sections
were processed for immunocytochemistry. The NaIO4 is an
oxidizing agent which attacks the hydrophobic alkane side-
chains of epoxy resin (Bendayan and Zollinger, 1983; Causton,
1984) making the sections more hydrophilic and allowing
a closer contact between immunogold-conjugated antibodies
and the antigens exposed on the surface of each section.
The solution enables the detection of specific immunogold
placement within a context of subcellular integrity, which
allows counting molecules within well-delineated specific cell
compartments.
Immunocytochemistry
Grids were treated with cold PBS containing 10% goat serum and
0.2% saponin to block non-specific antigenic sites for 20 min at
room temperature.
Following the blocking step, samples were incubated with
two primary antibodies in order to obtain a co-localization
(either with LC3 + P20S, LC3 + beclin-1, LC3 + 19S; P20S
+ beclin-1; P20S + 19S). The different primary antibodies
were: anti-LC3 (Abcam, Cambridge, UK, diluited 1:50); anti-
beclin-1 (Abcam, Cambridge, UK, diluited 1:50); anti-P20S
(Abcam, Cambridge, UK, diluited 1:10); anti-PA700 (19S/PA700
Chemicon, Temecula, CA, USA). Antibodies against 19S
proteasome subunit and the ATG marker beclin-1 were used
only for validating the co-localization of ATG and UP with
autophagoproteasomes. Only LC3 and P20S antibodies were
used for counts at ultrastructural morphometry. Antibody
specificity was assessed by a number of studies which were
partially reported in Table 1 (extramural evidence) and they
were routinely used for at least 10 years in our lab (intramural
evidence). The marker specificity meant as the subcellular
structures which were the object of this study (vacuoles) was
assessed in full agreement with the third edition of the Guidelines
for the use and interpretation of assays for monitoring autophagy
(Klionsky et al., 2016).
Incubations were carried out in ice cold PBS containing 1%
goat serum and 0.2% saponin in a humidified chamber overnight
at 4◦C.
Ultrathin sections were washed in cold PBS, they were
incubated with gold-conjugated secondary antibodies (10 nm
gold particles anti-LC3; 20 nm gold particles anti-P20S, BB
International), and they were diluted 1:20 in PBS containing
1% goat serum and 0.2% saponin for 1 h, at room temperature.
After rising in PBS, grids were incubated with
1% glutaraldehyde for 3 min, they were washed in distilled
water (to remove trace of salts and preventing precipitation
of uranyl acetate), and they contrasted with uranyl acetate
(saturated solution in distilled water) and lead citrate to be
finally observed by using a Jeol JEM SX 100 electron microscope
(Jeol). Control sections were obtained by omitting the primary
antibody and by incubating with the secondary antibody only.
Assessment of Autophagy-Like Vacuoles,
LC3 Positive, and/or P20S Positive
Vacuoles
Pellets from U87MG cell lines allow an appropriate condition for
quantitative morphometry since ultrathin sections contain cells
randomly oriented owing a similar chance to be selected. In fact,
counts obtained from different cell pellets are very consistent as
witnessed by the small standard error (Ylä-Anttila et al., 2009;
Lenzi et al., 2012).
Ultrastructural morphometry was carried out at 8000×
magnification in order to distinguish autophagy (ATG)-like
TABLE 1 | Sources and references for all the antibodies reported in the
present study.
Antibodies References
LC3 (Nanotools) Ladoire et al. (2012), Hiniker et al. (2013),
Martinet et al. (2013), Koukourakis et al. (2015)
LC3 (Santa Cruz) Balgi et al. (2009), Hu et al. (2012),
Chen et al. (2013), Lisiak et al. (2014)
LC3 (Abcam) Porter et al. (2013), Chen et al. (2014b),
Pla et al. (2014), Wang et al. (2014)
LC3 (Sigma) Klionsky and Emr (2000), Klionsky et al. (2003),
Kuma et al. (2004)
Proteasome 20S (Abcam) Hendil et al. (1995), Kovarik et al. (2010),
Vilchez et al. (2012), Stout et al. (2013)
Proteasome 20S (Chemicon) Castino et al. (2008)
Beclin I (Abcam) Chen et al. (2012, 2014a), Abdulrahman et al. (2013)
Beclin I (Santa Cruz) Lenzi et al. (2012), Guo et al. (2015)
19S/PA700 (Abcam) Sun et al. (2005), Rousseau et al. (2009),
Zhou et al. (2011)
19S/PA700 (Chemicon) Castino et al. (2008)
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vacuoles and LC3 or P20S vacuoles and LC3 + P20S positive
vacuoles. Each grid contained non-serial sections, and for each
grid we observed an average of 10 cells. Several grids were
observed in order to obtain a total number of 50 cells from each
experimental group.
We scored as ATG-like vacuoles both, double or multiple
membranes (autophagosomes-like) containing cytoplasmic
material and electrondense membranous structures according
to previous studies (Fornai et al., 2007; Lenzi et al., 2012). We
counted the number of ATG-like vacuoles for each cell, and then
we calculated the mean value per cell. Authentic ATG vacuoles
were instead defined by the occurrence of LC3 with an ATG-like
vacuole. Moreover, we calculated the percentage of LC3 only,
P20S only and LC3 + P20S positive vacuoles.
Count of Immunogold Particles
Measurement of immunogold particles (10 nm or 20 nm)
placed in the cytosol, or within ATG vacuoles was carried out
by electron microscopy at 8000× magnification according to
Lucocq et al. (2004). In fact, 8000× corresponds to the minimal
magnification at which gold particles and cell compartments can
be still identified concomitantly with whole organelles and big
cell compartments.
Grid squares containing labeled cells were chosen randomly
to start the count. In particular, starting at a grid square
corner, the whole of the sectioned pellet within that grid
square was scanned continuously in equally spaced parallel
sweeps across the specimens. Random selection makes
the quality of the scanning independent either from cell
density or intensity of gold labeling. For LC3 and P20S,
in each cell we counted the number of anti-LC3 or anti-
P20S immunogold particles placed in the cytoplasm, and
we expressed the mean value of immunogold particles
for cell out of 50 cell counted. Moreover, we counted the
number of anti-LC3 or anti-P20S immunogold particles
within ATG-like vacuoles (to identify autophagosomes
and autophagoproteasomes as reported above). For co-
localization, we counted the ATG-like vacuoles that possessed
both immunogold particles (10 nm for LC3 and 20 nm for
P20S).
Statistics
For confocal microscopy the amount of P20S + LC3 puncta were
counted. Values were expressed as the mean number of puncta
per cell counted in two separate experiments each one carried
out in duplicate. We counted 50 cells for each group.
For ultrastructural morphometry values were expressed using
the absolute value: (i) ATG-like vacuoles; (ii) cytosolic LC3 or
P20S immunogold particles; (iii) LC3 or P20S-positive vacuoles;
(iv) P20S + LC3-positive vacuoles; or as percentage of normal
numerical distributions: (i) LC3 or P20S and P20S + LC3
positive vacuoles out of total ATG-like vacuoles; (ii) the number
of LC3 or P20S immunogold particles within vacuoles out
of total immunogold particles of LC3 or P20S respectively;
(iii) P20S + LC3 positive vacuoles out of the single positive
vacuoles (LC3 solely and P20S solely, respectively). Moreover,
values for ultrastructural morphometry were also expressed
as a ratio as follows: (i) cytosolic LC3 or P20S particles
out of total ATG-like vacuoles; (ii) LC3-positive vacuoles
out of total P20S-positive vacuoles and the reciprocal value;
(iii) cytosolic P20S particles out of cytosolic LC3 particles;
(iv) P20S particles within vacuoles out of cytosolic P20S
particles. These data were obtained in a total of 50 cells per
group which were randomly harvested from three separate
experiments. Indeed, the high consistency of each value made
the randomization useless since the mean obtained for each
value from each group were overlapping the values we constantly
measured during the past decades in pilot non-systematic
experiments. Nonetheless, in the recent data collection we wish
to systematically establish the mild variability of these biological
phenomena which led to S.E.M often ranging around 5% of the
mean.
Data are reported as the mean or the mean percentage
± S.E.M.
Inferential statistics to compare groups was carried out by
using one-way analysis of variance, ANOVA, with Sheffè’s post
hoc analysis (H0, null hypothesis, was rejected for P ≤ 0.05).
RESULTS
Ultrastructural Studies
Plain Transmission Electron Microscopy of
Autophagy-Like Vacuoles
The typical ultrastructure of U87MG cells in baseline conditions
is represented in Figure 1 showing depressed autophagy
activity as expected from mTOR up-regulation, which
occurs in this cell line, which in turn produces only a few
ATG-like vacuoles. Accordingly, as shown in representative
pictures reported in Figures 1A–E and in the graph of
Figure 1F the amount of ATG-like vacuoles which was
counted by using plain electron microscopy dose-dependently
increases under the effects of the mTOR inhibitor rapamycin
(Figures 1D,E compared with Figure 1A). In detail, the
number of vacuoles dramatically increased following the highest
dose of rapamycin (1 µM), which leads to a roughly 7-fold
increase. The consistency of these phenomena is witnessed
by the low variability in the mean obtained from 50 cells
from each group as it appears from the S.E.M. of each value
(Figure 1F).
LC3 Immunocytochemistry
When measured at high magnification counts of immunogold
staining it confirmed low baseline ATG activity as indicated by
depressed levels of the ATG hallmark protein LC3 (Figure 2A).
This effect was widespread in the cell, independently from
which specific compartment was analyzed (ATG-like vacuoles,
mitochondria or other structures). In keeping with the increase
in ATG-like vacuoles counted in Figure 1F, we documented
a dramatic amount in cytosolic LC3 immunogold particles
under the effects of rapamycin (Figure 2A). Remarkably,
such an increase was dose-dependent, similarly to that
measured for ATG-like vacuoles for the highest dose of
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FIGURE 1 | Plain electron microscopy of U87MG cells. Representative pictures of ATG-like vacuoles in the cytoplasm in baseline conditions (arrows) (A) and
after increasing doses of rapamycin (B–E) as visualized in representative micrographs. The mean number of ATG-like vacuoles per cell was counted and values were
reported in graph (F). This graph shows that rapamycin induces dose-dependently (1 nM; 10 nM; 100 nM and 1 µM) an increase in the number of ATG-like vacuoles
compared with baseline conditions (B). Values are given as the mean ± S.E.M. Comparisons between groups were made by using one-way ANOVA. ∗P ≤ 0.05
compared with baseline conditions. Scale bars (A–E) = 1µm.
rapamycin (185.68 ± 6.06 compared with 38.54 ± 2.40
for baseline conditions, Figure 2A). The analogy between
these effects was confirmed by counting the ratio between
LC3 immunogold particles and ATG-like vacuoles in baseline
conditions and following increasing doses of rapamycin.
These counts are reported in Figure 2B, which demonstrates
that the ratio remains steady in baseline conditions and
following increasing doses of rapamycin. This suggests that
both the widespread increase of LC3 we measured in the
cytosol and the increase of ATG-like vacuoles depend on
the same phenomenon relying on rapamycin-induced mTOR-
inhibition, which in turn, produces ATG stimulation. In fact,
when counting the number of authentic LC3-positive ATG
vacuoles (which represent the gold standard structures to
assess the autophagy status, see representative Figure 2C)
we could document the increase in ATG activity induced
by rapamycin, which produced a significant increase in the
absolute number of LC3-positive ATG vacuoles (Figure 2D).
Again, the magnitude of such an increase overlaps with
that measured for ATG-like vacuole and for LC3 cytosolic
particles as previously reported (Figures 1F, 2A, respectively).
In order to further validate the measurement of LC3 cytosolic
particles and ATG-like vacuoles we measured the percentage
of LC3 positive vacuoles out of total ATG-like vacuoles.
This measurement led to a roughly half of authentic (LC3
positive) ATG vacuoles out of total ATG-like vacuoles.
Remarkably, such a percentage was not modified by ATG
activation and it remained steady along increasing doses
of rapamycin (Figure 3A). Again, when the percentage of
LC3 particles within vacuoles was counted out of total LC3
particles we detected steady values (Figure 3B). These latter
data indicate that the vacuoles we counted as ATG-like
are indeed roughly double of authentic (LC3 positive) ATG
vacuoles. It is likely that ATG-like vacuoles do correspond
to authentic ATG vacuoles since they are similarly depressed
in baseline conditions and they similarly increase under
rapamycin administration. Thus, the issue of defining ATG
vacuoles as ATG-like is rather methodological. In fact,
it is likely that the thickness of the ultrathin electron
microscopy sections which is roughly a half of the diameter
of an ATG vacuole leads to a 50% chance to detect
LC3 particles within the vacuoles which are likely to be,
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FIGURE 2 | LC3 immunocytochemistry. The number of cytosolic LC3 immunogold particles significantly increases dose-dependently after rapamycin (1; 10; 100;
nM and 1 µM) compared with baseline conditions (B) as reported in graph (A). When rapamycin-dependent increase in immunogold particles was plotted vs.
rapamycin-dependent increase in ATG-like vacuoles reported in Figure 1F, we measured a similar trend as witnessed by the steady values reported in graph (B) for
baseline conditions (B) and different doses of rapamycin (1 nM; 10 nM; 100 nM and 1 µM). This suggests that LC3 particles and ATG-like vacuoles express the
same phenomenon (ATG status). To confirm this analogy we carried out LC3 immunocytochemistry for ATG vacuoles as shown in representative picture (C) where
authentic ATG vacuoles possessing different shapes and a double membrane were stained with LC3 immunogold particles (shown by arrows; gold standard
procedure according to Klionsky et al., 2016). This procedure allowed to count authentic ATG LC3-positive vacuoles, which were reported in graph (D). This graph
shows that rapamycin induces dose-dependently (1 nM; 10 nM; 100 nM and 1 µM) an increase in the number of ATG LC3-positive vacuoles compared with baseline
conditions (B). The increase in ATG-like vacuoles observed in Figure 1F was matched by such an increase in ATG LC3-positive vacuoles reported in panel D. In (C)
vacuoles stained with LC3 immunogold particles (arrows) show different shape. The absolute number of LC3-positive vacuoles increases dose dependently (D).
Values are given as the mean ± S.E.M. Comparisons between groups were made by using one-way ANOVA. ∗P ≤ 0.05 compared with baseline conditions. Scale
bar (C) = 250 nm.
in any case, authentic ATG structures. This concept is in
line with what recently expressed by Lucocq and Hacker
(2013).
P20S Immunocytochemistry
Despite the vacuoles counted at plain TEM or following
immunostaining correspond to ATG organelles, in the past
decades, during various experiments, we noticed that proteasome
components could be detected at this level. Therefore, in line
with the purpose of the study, we detailed the occurrence
of UP components within these ATG vacuoles. As shown in
representative Figures 4A,B we confirmed the presence of both
P20S and 19S (PA700), respectively, within ATG-like vacuoles.
Thus, as it was carried for LC3 (Figure 2A) we counted the
amount of P20S-immunogold particles in baseline conditions
and under ATG stimulation (i.e., rapamycin). Remarkably,
despite the absolute number of P20S in baseline conditions was
lower than LC3 (1.74 ± 0.16 compared with 38.54 ± 2.40,
respectively), the increase we counted in P20S particles was
remarkable (24.04 ± 2.75, at 1 µM rapamycin compared with
1.74 ± 0.16, in baseline conditions, Figure 4C). Similarly
to LC3, despite both P20S particles and ATG-like vacuoles
increased significantly under the effects of rapamycin their
ratio stays steady (Figure 4D). Remarkably, when we counted
the number of P20S positive vacuoles we found that although
they were present in baseline conditions, there was a dose-
dependent increase in P20S positive vacuoles occurring following
rapamycin (Figure 5A). This increase was reminiscent of that
Frontiers in Neuroanatomy | www.frontiersin.org 7 July 2016 | Volume 10 | Article 78
Lenzi et al. The New Organelle Autophagoproteasome
FIGURE 3 | Comparisons between LC3 immunostaining and ATG
vacuoles. As hypothesized from the similarities between graphs
Figures 1F,D, when we plotted the mean number per cell of LC3 positive
vacuoles vs. the mean number per cell of ATG-like vacuoles expressed as
percentage (A) we failed to observe any significant difference for different
doses of rapamycin (1 nM; 10 nM; 100 nM and 1 µM) and baseline conditions
(B). This confirms the same nature of both phenomena (ATG status). In fact,
the values remained steady also in graph (B) when the dose-dependent
increase in the number of LC3 particles within vacuoles was plotted vs. the
dose-dependent increase in the number of total LC3 particles for increasing
doses of rapamycin (1 nM; 10 nM; 100 nM and 1 µM) and baseline conditions
(B). Thus, graph (B) confirms that LC3 increase expresses the increase in
authentic ATG vacuoles. Values are given as the mean percentage ± S.E.M.
Comparisons between groups were made by using one-way ANOVA.
occurring for LC3 as reported in Figure 2D. In fact, when
the ratio between LC3 positive vacuoles and P20S positive
vacuoles (and vice versa, two reciprocal graphs of Figure 5B)
was plotted in baseline conditions and following different
doses of rapamycin values were quite steady (Figure 5B),
despite a slight increase of LC3 over P20 vacuoles at lower
rapamycin doses and the opposite trend for the highest
doses of rapamycin (see reciprocal graphs of Figure 5B).
This slight effect suggests a prevalence of ATG vs. UP for
low mTOR inhibition with a shift towards a more UP-based
clearance for higher extent of mTOR inhibition. Of course
these data are merely based on protein amount and need
further studies to confirm whether this translates into enzymatic
activity.
Altogether graphs Figures 5A,B indicate that P20S just like
LC3 is increased by rapamycin within ATG vacuoles. Thus,
both ATG and UP markers, associate significantly with ATG
vacuoles. This is further confirmed by graph Figure 5C showing
that the ratio between the dose-dependent increase in P20S
particles within vacuoles and the increase in the total number
of cytosolic P20S particles similarly results in steady values
(Figure 5C). This latter graph overlaps again with what reported
for LC3 particles in Figure 3B. This means that neither LC3
(Figure 3B), nor P20S (Figure 5C), vary their percentage
of compartmentalization within vacuoles following increasing
doses of rapamycin. It is remarkable that despite the net amount
of P20S is way lower compared with LC3 (Figures 2A, 4C) the
percentage of compartmentalization of these molecules within
ATG-like vacuoles is similar for LC3 (Figure 3B) and P20S
(Figure 5C) in baseline conditions and after different doses of
rapamycin. This indicates that P20S is related with ATG vacuoles
as much as LC3. Similarly to LC3, the percentage of P20S
immunopositive vacuoles was not modified following rapamycin
(Figure 5D).
The results of ultrastructural morphometry carried out
so far, distinctly for LC3 and P20S, demonstrate a number
of similarities for these two markers in relationship with
ATG vacuoles. In fact, both markers respond similarly
to dose-dependent inhibition of mTOR. Nonetheless, the
occurrence of LC3 is much abundant than P20S in baseline
condition which makes the percentage of LC3 positive
vacuoles higher than P20S positive vacuoles. However, this
difference is significantly attenuated by the highest dose
of rapamycin. This suggests that LC3 and P20S similarly
increase following maximal mTOR inhibition however the
polarization of their placement towards ATG vacuoles is
higher for P20S compared with LC3. This makes LC3 a
more abundant and specific marker for ATG vacuoles but it
indicates that the placement of P20S within ATG vacuoles
is more sensitive to the amount of mTOR inhibition. In
fact, when we measured the ratio between the amount of
cytosolic P20S over cytosolic LC3 in baseline conditions and
following the highest dose of rapamycin, we found that the
increase in P20S particles significantly exceeded the increase
in LC3 particles (Figure 6A). The significance of this finding
is further magnified by considering that the ratio between
compartmentalized P20S within vacuoles over dispersed
cytosolic P20S increased two-fold for the highest dose of
rapamycin (Figure 6B).
P20S + LC3 Immunocytochemistry
As shown in representative Figures 7A,B, the P20S proteasome
marker co-localizes with ATG markers such as LC3 (Figure 7A)
and beclin-1 (Figure 7B). When considering the gold
standard marker LC3 for quantitative morphometry, we
could demonstrate that a few percentage of what was
once defined the classic ATG vacuole (LC3 positive)
may also stain for the proteasome marker P20S. This co-
localization generates a novel entity which corresponds to
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FIGURE 4 | Ultrastrucure of ubiquitin proteasome (UP) components and their presence within ATG-like vacuoles. UP components were identified by
immunocytochemistry against either P20S or 19S/PA700 as shown in representative micrograph (A) where arrowheads show P20S-bound immunogold particles
and representative micrograph (B) where arrowheads show 19S/PA700-bound immunogold particles. In both (A,B) these proteasome components are shown in the
context of multiple membranes ATG-like vacuoles shown by arrows. However, the presence of UP component also occurred in the cytosol. In fact, as measured in
graph (C), we carried out an extensive count of total cytosolic UP component. For these counts we used P20S immunogold particles. Again, even in this case we
measured a dose-dependent increase in the number of P20S particles for increasing doses of rapamycin (1 nM; 10 nM; 100 nM and 1 µM) number of ATG-like
compared with baseline conditions (B,C). When we compared such a rapamycin-dependent increase in cytosolic UP components with the dose-dependent
increase in ATG-like vacuoles primarily expressed by graph Figure 1F we obtain graph (D) showing that the ratio between P20S immunogold particles out of total
ATG-like vacuoles was steady for increasing doses of rapamycin (1 nM; 10 nM; 100 nM and 1 µM) number of ATG-like compared with baseline conditions (B,D).
Values are given as the mean ± S.E.M. Comparisons between groups were made by using one-way ANOVA. ∗P ≤ 0.05 compared with baseline condition. Scale
bars (A,B) = 112 nm.
the autophagoproteasome. Remarkably, in the present study,
when counting this double immunostaining we found that
the amount of autophagoproteasomes reported in graph
Figure 7C is similar to the amount of P20S positive vacuoles
counted in Figure 5A. This indicates that P20S positive
vacuoles are mostly LC3 + P20S positive autophagoproteasomes.
The occurrence of these double clearing vacuoles is lower
compared with classic LC3 positive autophagosomes. This
is in line with the lower amount of P20S in the cell (both
in the cytosol and within autophagy vacuoles) compared
with LC3. However, the amount of P20S positive vacuoles
and LC3 + P20S positive vacuoles are almost overlapping
which suggests that autophagoproteasomes are well defined
by the presence of P20S within an LC3 positive vacuole.
Interestingly, despite the net increase in all vacuoles (both
LC3 positive autophagosomes and LC3 + P20S positive
autophagoproteasomes) under the effects of increasing doses
of rapamycin, the percentage of LC3 + P20S out of total ATG
vacuoles (Figure 7D) and out of LC3 positive ATG vacuoles
(Figure 8A) stay quite steady, despite a slight increase. This
indicates that increasing mTOR inhibition produces a quite
harmonic expression of both clearing pathways leaving intact the
ratio between autophagosome and autophagoproteasomes. It is
remarkable though, that for the highest dose of rapamycin there
was a two-fold increase in autophagoproteasome compared
with sole P20 positive vacuoles (Figure 8B). This latter
finding suggests that co-localization of P20S within LC3
positive vacuoles prevails for the highest doses of rapamycin.
This would be in line with the fact that pure proteasomal
degradation is unlikely under powerful ATG stimulation which
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FIGURE 5 | Significance of increases in P20S compared with LC3 and ATG vacuoles. As expected from graph Figure 4D, the number of P20S-positive
vacuoles increases dose-dependently for increasing doses of rapamycin (1 nM; 10 nM; 100 nM and 1 µM) compared with baseline conditions (A,B). Such an
increase possessed the same trend of those observed either for LC3-immunogold or for ATG vacuoles. However, slight though significant differences can be
detected. In fact, when plotting the number of LC3 on P20S positive vacuoles or vice versa (upper and lower graph of B), we found a significant prevalence of LC3
over P20S for lower rapamycin doses which was reciprocated by a prevalence of P20S over LC3 for higher rapamycin doses (B upper and lower graph,
respectively). This subtle difference in the dose-dependent increase in components belonging to different clearing systems indicates that mTOR inhibition by
rapamycin is expected to produce dose-dependent different stimulations of ATG and UP. This difference should not be misleading since in both cases both systems
are overexpressed. Despite a total increase, when the amount of P20S-positive vacuoles was plotted vs. the number of total P20 particles the percentage values for
each dose of rapamycin and baseline conditions remained steady (C) apart from a slight decrease for the lowest dose of rapamycin. Again, confirming the similar
nature of P20S-positive vacuoles with ATG components, we measured the same percentage of P20S-positive vacuoles out of the total ATG-like vacuoles following
different doses of rapamycin (1 nM; 10 nM; 100 nM and 1 µM) and baseline conditions (B,D). Values are given as the mean or percentage of the mean ± S.E.M.
Comparisons between groups were made by using one-way ANOVA. (A) ∗P ≤ 0.05 compared with baseline condition. (B) ∗P ≤ 0.05 compared with the other
groups.
appears to improve a combined ATG + UP clearing organelle
instead.
In Figure 9 we report the co-localization of P20S and LC3
in PC12 cells as shown in representative picture. The amount
of autophagoproteasome we counted in ultrathin sections in this
rat-derived cell line is 0.26± 0.06. This data need to be corrected
based on cell surface. Since the surface of PC12 cells is roughly a
half of U87MG, we measured a density of autophagoproteasome
in PC12 which is two-fold the density counted in U87MG.
Confocal Microscopy
In order to provide further evidence of merging between ATG
and UP components we carried out a few representative confocal
microscopy experiments to document merging between ATG
andUP reported in representative Figures 10A–C showing at low
magnification the occurrence of P20S and LC3 immunostaining
which merge at the level of autophagoproteasomes. When
compared with TEM micrograph, the occurrence of P20S
immunostaining is even more polarized towards LC3
immunopositive area. In contrast, LC3 immunostaining
possess a significant amount of single (non-merging) staining.
This is emphasized when analyzing confocal images at higher
magnification as shown in Figures 11A–C. At highmagnification
confocal microscopy P20S and LC3 immunostaining co-
localize in U87 cells. In Figure 11C a representative image of
merging at confocal microscopy provides a rough visualization
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FIGURE 6 | P20S-positive compared with LC3-positive particles and
P20-positive vacuoles. Graph (A) confirms a more pronounced increase in
UP vs. ATG components (P20S compared with LC3) for the highest dose of
rapamycin. In fact, both P20S and LC3 particles increase dose-dependently
for increasing doses of rapamycin (1 nM; 10 nM; 100 nM and 1 µM)
compared with baseline conditions (B) but the highest dose of rapamycin
which produced a significantly higher increase for P20S compared with LC3.
The ratio between compartmentalized P20S within vacuoles out of total
cytosolic P20S shows a steady trend towards higher values following
rapamycin compared with baseline (B). Values are given as the
mean ± S.E.M. Comparisons between groups were made by using one-way
ANOVA. ∗P ≤ 0.05 compared with baseline condition.
of an autophagoproteasome despite that no specific cell
compartment can be identified. In graph of Figure 11D
the mean number of autophagoproteasomes per cell is
reported in baseline conditions, which provide quantitative
measurement of what could be already appreciated at low
magnification in Figure 10. When cells are exposed to the
mTOR inhibitor rapamycin at the dose of 1 µM there is a
significant increase in the number of autophagoproteasomes-
like structures which increase roughly two-fold compared
with those counted in baseline conditions. Remarkably, this
corresponds to the two-fold increase in autophagoproteasomes
of Figure 8B. Due to a lower resolution of confocal compared
with TEM, there is an underestimation in the number of
autophagoproteasomes, which was calculated using confocal
microscopy compared with immuno-electron microscopy
(see ‘‘Discussion’’ Section). For the same reason, the amount
of immunopositive puncta both in baseline and stimulated
conditions is way lower compared with immunogold
particles counted at electron microscopy. This discrepancy
likely relies on the sensitivity of the methods as reported
in the ‘‘Discussion’’ Section. When counted at TEM, the
amount of P20S positive vacuoles is comparable with the
amount of P20S + LC3 positive vacuoles, which corresponds
exactly to the overlapping between P20S positive puncta
and merging (P20S + LC3) positive puncta observed at
confocal microscopy. However, when observed at TEM,
immunogold P20S positive particles exceeds the number of
P20S particles within vacuoles. This indicates that at TEM all
P20S particles are stochietrically detected, whereas at confocal
microscopy this occurs only when P20S is present within
vacuoles.
At confocal microscopy a quantitative measurement of LC3
immunopositive puncta was technically impossible due to a
spreading of immunofluorescence from the great amount of
sources (LC3 immunofluorescent bodies) which contrasts with
the clear-cut localization and quantitation of LC3 immunogold
particles at TEM.
Co-Immunoprecipitation of LC3B-I/II with
Proteasome 20S
The results presented so far provide a solid evidence for
the existence, modulation and quantitation of the novel
organelle autophagoproteasome validated at morphological level.
However, the presence of two clearing pathways (ATG and UP)
within the same organelle does not tell much about their potential
interaction. Therefore, in order to assess whether ATG (LC3)
and UP (P20S) components interact at molecular level we carried
out co-immunoprecipitation experiments. Expression of LC3-
II/I was detected in the U87MG cells (Figure 12). Lysates of cells
were immunoprecipitated with anti LC3 antibody (3 mg for each
sample; Sigma Aldrich, Milan, Italy) and then immunoblotted
with anti-P20S (1:100; Abcam).
The P20S was detected in LC3 immunopositive structures of
immunoprecipitates from U87MG cells in baseline conditions.
These data strongly suggest a molecular binding between LC3
and P20S.
Remarkably, after rapamycin administration LC3-II/I
levels dose-dependently increased in immunoprecipitates. In
detail, we observed an increase in the ratio between LC3-
II and LC3-I which confirms that ATG was activated. In
both baseline conditions and following rapamycin, P20S
co-immunoprecipitated without any noticeable difference
between baseline and rapamycin as shown in representative
Figure 12. These latter results may apparently contrast with
the well documented increase in the amount of P20S under
the effects of rapamycin previously shown. However, it
should be kept in mind that an increase in P20S within the
cell within the same organelle as LC3 may not correspond
to an increase in molecular interactions between LC3 and
P20S. Such an interaction may be even reduced under
ATG activation. In any case, the significance of these data
consist in demonstrating both in baseline conditions as
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FIGURE 7 | Occurrence of autophagoproteasome. When LC3 and P20S immunogold staining was carried out concomitantly the occurrence of both P20S
particles and LC3 particles within the very same ATG vacuoles was documented as shown in representative micrograph (A). In this picture P20S staining is
represented by 20 nm immunogold particles evidenced by arrowheads, while LC3 staining is represented by smaller (10 nm) immunogold particles evidenced by full
thin arrows. To further validate co-localization of UP with ATG components P20S staining was also combined with another specific marker of ATG which is Beclin-1
(B). In both micrographs (A,B) thick arrows point to double membranes limiting vacuoles. The co-localization of P20S immunogold particles (20 nm; arrowheads)
with Beclin-1 immunogold particles (10 nm, arrows) within a vacuole confirms the existence of a merging organelle named autophagoproteasome. When the mean
number of autophagoproteasomes occurring in the cell was counted in graph (C) a dose-dependent increase of P20S + LC3 positive vacuoles after rapamycin (1
nM; 10 nM; 100 nM and 1 µM) compared with baseline conditions (B) was documented. In order to correlate the occurrence of autophagoproteasome with the
amount of the primary ATG-like vacuoles measured in Figure 1F, we calculated the percentage of LC3 + P20S positive vacuoles out of total ATG-like vacuoles (D).
Remarkably, such percentage remains steady following increasing dose of rapamycin (1 nM; 10 nM; 100 nM and 1 µM) compared with baseline conditions (B).
Values are given as the mean or the percentage of the mean ± S.E.M. Comparisons between groups were made by using one-way ANOVA. ∗P ≤ 0.05 compared
with baseline condition. Scale bars (A) = 140 nm; (B) = 118 nm.
well as following mTOR inhibition that a molecular link
binds ATG and UP markers (either within cytosol and/or
within vacuoles). The nature of this potential binding is
unknown, although it is likely that ubiquitin chains may play
a role. Further studies are in progress to assess this intriguing
point.
DISCUSSION
The present study provides a solid morphological evidence
indicating that the two major clearing pathways of eukariotic
cells (autophagy and proteasome) converge at the level of single
organelles named autophagoprotesomes. This is validated by
using different gold standard markers for both pathways (LC3
and beclin-1 for ATG; P20S and 19S/PA700, for UP). The co-
localization occurs at the level of double or multiple membrane
vacuoles. The occurrence of proteasome components within
these vacuoles was extensively documented by stoichiometric
measurements of each molecule by immunogold-aided TEM.
Further evidence was provided at a lower resolution by
representative and quantitative confocal microscopy which
measured the presence of autophagoproteasomes. The
occurrence of autophagoproteasomes is evident already in
baseline conditions both at electron and confocal microscopy.
However, both techniques indicate a dose-dependent increase
in these organelles when the mTOR inhibitor rapamycin is
administered. The increase in autophagoproteasomes under the
dose-dependent effects of rapamycin is more pronounced at
electron compared with confocal microscopy. Such a difference
depends on the lower resolution of confocal microscopy
compared with TEM, where single proteins merging within
a vacuole are detected. In contrast, only high amount of
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FIGURE 8 | The occurrence of autophagoproteasomes compared with either LC3- or P20S-positive vacuoles. In order to compare the occurrence of the
autophagoproteasome with the occurrence of total vacuoles positive for LC3 or P20S we measured the ratio between P20S + LC3 positive vacuoles and LC3
expressed as percentage graph (A) or the ratio between P20S + LC3 positive vacuoles and P20S expressed as percentage graph (B). These measurements were
carried out after rapamycin (1 nM; 10 nM; 100 nM and 1 µM) compared with baseline conditions (B). Remarkably, when the percentage of autophagoproteasome
was calculated out of total LC3-positive vacuoles the graph shows steady values; in contrast, when the amount of autophagoproteasomes was plotted against
P20S-positive vacuoles, we noticed a significant augmentation in autophagoproteasomes increase which is likely to depend on the trend of the few P20S particles to
be dragged by the abundant LC3 molecules to localize within the same compartment under the increasing mTOR inhibition produced dose-dependently by
rapamycin (B). For the highest dose of rapamycin most of P20S positive vacuoles are both LC3 and P20S positive which suggests that P20S vacuoles almost
correspond to LC3 + P20S positive vacuoles when mTOR is strongly inhibited. Values are given as the mean or the percentage of the mean ± S.E.M. Comparisons
between groups were made by using one-way ANOVA. ∗P ≤ 0.05 compared with baseline condition.
molecules provide a detectable signal at fluorescence confocal
microscopy. The occurrence of autophagoproteasomes in
baseline conditions is remarkable when considering the
FIGURE 9 | Electron microscopy of autophagoproteasome in PC12
cells. The concomitant occurrence of P20S and LC3 immunostainig within a
double membrane (thick arrows) vacuole is shown in representative
micrograph. The LC3 staining is shown by small (10 nm) immunogold particles
indicated by thin arrows while P20S staining is shown by large (20 nm)
immunogold particles indicated by arrowheads. This confirms in a rat-derived
cell line convergence between autophagy and proteasome in the novel
clearing organelle autophagoproteasome. Scale bars = 75 nm.
experimental setting we selected to carry out the present
experiments. In fact, GBM cell lines highly express mTOR,
which in turn suppresses ATG (Jiang et al., 2009). We selected
on purpose these experimental conditions to hardly challenge
our experimental hypothesis. In fact, if the occurrence of
autophagoproteasomes as a morphological entity is a noticeable
anatomical effects, this should be detectable even when only a
few vacuoles are present in the cell. In fact, we demonstrated
that autophagoproteasomes can be documented even when
mTOR is overactive and ATG is inhibited. This indicates that
such an organelle persists even in detrimental ATG conditions.
As expected, when ATG was recovered by a dose-dependent
mTOR inhibition, the occurrence of autophagoproteasomes
blossomed up to higher levels compared with LC3 positive ATG
vacuoles observed in baseline conditions. The occurrence of
ATG stimulation under the effects of mTOR inhibition induced
by rapamycin was confirmed in the present experimental
conditions by using a variety of internal controls. In fact,
we concomitantly measured an increase of the following
items: double-membrane vacuoles, LC3 positive vacuoles, LC3
particles in the cytosol. All these markers measured at TEM
are gold standards to identify ATG structures, which were
augmented dose-dependently by rapamycin administration.
Thus, the autophagoproteasome remarkably overlaps the trend
of the cell ATG status and it is equally stimulated by a classic
ATG stimulator. Unexpectedly, in this research article we
clearly documented that rapamycin, apart from its mTOR-
dependent ATG stimulation, strongly and dose-dependently
overexpressed UP components. The amount of overexpression
of P20S, again, overlapped with LC3 and ATG vacuoles.
Altogether these data indicate that cell clearing pathways,
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FIGURE 10 | Confocal microscopy of autophagoproteasomes low magnification. Confocal microscopy confirms the occurrence of autophagoprotesome as
shown by representative images at low magnification. At the highest dose of rapamycin the amount of P20S immunostaining (A) is scattered in the cell and only a
few red puncta were observed (arrows). At this magnification the difference between P20S immunostaining and the intense LC3 immunostaining as shown by green
puncta (arrows) is even more evident (B). Co-localization of P20S + LC3 within the same cells was shown by merging as orange/yellow puncta (arrows) (C). Again
these representative pictures at low magnification indicate that, for the highest doses of rapamycin, P20S is mostly dragged down within LC3 positive vacuoles
making it more compartmentalized than LC3 itself. Scale bar = 12 µm.
which where once considered to be distinct morphological
entities undergoing a distinct metabolic regulation, indeed
represent a unified morphological clearing apparatus. At
this level all components eventually merge sharing at least
some common regulators which rely on the status of mTOR
activity. The functional merging is not solely grounded on
the presence of similar activators or the convergence within
multi-membrane structures, but it is strongly implicated by
the occurrence of remarkable co-immunoprecipitation of LC3
and P20S. These latter findings rely on either direct or indirect
binding between these molecules. So far, no data are available
showing all these evidence and no study addressed neither the
morphology of autophagoproteasome nor a binding between
LC3 and P20S. At present, we cannot provide the molecular
basis for such a binding. One might speculate that the key
clearance-related protein ubiquitin may be a good candidate
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FIGURE 11 | Confocal microscopy of autophagoproteasomes low magnification. When confocal microscopy was observed at higher magnification the
occurrence of autophagoprotesomes was more evident. In fact, as shown in representative image (A) corresponding to the highest dose of rapamycin the amount of
P20S immunostaining is quite rare in the cell as shown by arrows marking only a few red puncta. This markedly contrasts with the intense blossoming of LC3
immunostaining showed in (B) where several green puncta are marked by arrows. In these cells single puncta are no longer distinguishable due to the spreading of
intense immunofluorescence. Remarkably, as suggested by graph Figure 8B and already evident at lower magnification in Figure 10, the very same puncta which
were labeled for P20S only (A) also stained for LC3 (C). Co-localization of P20S + LC3 is shown by merging orange/yellow puncta (arrows). These merging
structures do represent autophagoproteasomes. The amount autophagoproteasomes under the pressure of strong mTOR inhibition (causing ATG activation)
corresponds quite exactly to the amount of P20S-positive vacuoles since they are the same structures. In this way, representative images (Figures 10, 11) provide a
“one-glance evidence” of the numerical similarity between autophagoprotesomes and P20S positive vacuoles following 1 µM rapamycin which was measured in
graph Figure 8B. Again this suggests that, for the highest doses of rapamycin P20S is selectively dragged down within LC3 positive vacuoles making it more
compartmentalized than LC3 itself. This calls for testing whether potential molecular binding exists between these components. Confirming again what counted in
graph Figure 8B, when we measured merging puncta, in graph (D) we found that, for the highest dose of rapamycin, merged puncta increased two-fold compared
with baseline (B). In fact, graph (D) represents the number of P20S + LC3 positive puncta per cell. Values are given as the mean ± S.E.M. Comparisons between
groups were made by using one-way ANOVA. ∗P ≤ 0.05 compared with baseline conditions. Scale bar = 20 µm.
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FIGURE 12 | Immunoprecipitation with anti-LC3 antibody and
immunoblotting with anti-P20S. P20S is clearly detected by western
blotting carried out from LC3-immunoprecipitates from two baseline
conditions and following two doses of rapamycin (one for 1 nM and two for 10
nM). P20S is present in baseline conditions and following rapamycin. This
strongly suggests the occurrence of a molecular binding between LC3 and
P20S. The amount of P20S may either increase or decrease depending on
how much it is dragged down by LC3, which in turn depends on direct or
indirect binding between P20S and LC3 itself which occurs in each
experimental conditions. In fact, the intensity of the P20S band does not
correspond to P20S particles but it rather represent P20S particles bound to
LC3. This phenomenon suggests that the amount of binding between LC3
and P20S decreases when compared with the increase in LC3 and P20S
particles per se. This is likely to depend on the fact that despite increasing
P20S and LC3, mTOR inhibition also promotes the enzymatic conversion of
those structures bridging LC3 with P20S as reported in the “Discussion”
Section. The representative blotting shows a rapamycin-dependent increase
in the ratio between LC3-II and LC3-I which is consistent with
rapamycin-induced ATG activation as shown all over the article.
to constitute an intermolecular bridge. In fact, both ATG
and UP pathways are initiated upon substrate ubiquitination
(Clague and Urbé, 2010; Shaid et al., 2013). In keeping with
this, it should be considered that, when ATG progresses
physiologically the ATG marker LC3 is eventually metabolized,
which poses the question whether such a metabolism is
carried out upon poly-ubiquitination by UP complex within
autophagoproteasomes. Very recently it was demonstrated
that, during the native state of ATG organelles, at the level
of phagophores UP may engage substrates and terminate
protein clearance (Liu and Chen, 2016). A number of articles
which were published very recently analyzed the reciprocal
interactions between proteasome and autophagy by measuring
reciprocal variations of activity within various experimental
conditions (Ding et al., 2007; Zhu et al., 2010; Wang et al.,
2013; Zhang and Manning, 2015; Zhao et al., 2015). However,
none of these articles investigated the occurrence of a merged
morphological entity and, in general, no study addressed sub-
cellular compartmentalization of such a functional interaction.
In this manuscript we specifically defined this compartment as
a novel organelle, where hallmarks of both pathways actually
merge. From a functional level, despite slight differences it
is clear that expression of both ATG and UP markers within
these organelles are equally induced by mTOR inhibition.
Nonetheless a number of articles provided functional evidence
speaking out for the occurrence of proteasome inhibition when
ATG is stimulated (Buss et al., 2010; Zhang et al., 2015). This
apparently contrasts with present findings where we noticed
a concomitant expression of both components. However, the
discrepancy might be explained by some of our findings showing
that, when ATG is slightly activated there is an imbalance within
autophagoproteasome shifting towards an excess of ATG vs.
UP components, whereas upon maximal ATG activation the
reciprocal phenomenon occurs. In any case, if one considers
the absolute amount of ATG and UP proteins, they are both
increased following mTOR inhibition, which confirms the
recent findings by Zhao et al. (2015) showing that upon mTOR
inhibition both ATG and UP are activated. The functional
data based on ATG and UP activity are perfectly in line with
our morphological findings showing concomitant expression
of ATG and UP components following rapamycin. Most
importantly, this lends substance to a synergistic empowerment
of the autophagoproteasome which is made up by both
pathways.
Despite its morphological novelty autophagoproteasome
appears to be the natural site where cell clearing pathways (once
believed to be anatomically segregated) indeed co-exist and they
are likely to interact at molecular level. These data indicate that
ATG and UP often represent different facets of a single organelle
in which unexpected amount of enzymatic activity is potentially
available.
Thus, autophagoproteasome may represent a sophisticated
and complex ultimate clearing apparatus which is likely to
provide for a variety of physiological activities of the cell and
which is recruited by a variety of detrimental triggers.
Concerning this point, we wish to mention that the first
TEM evidence we obtained serendipitously for the placement
of UP components within ATG vacuoles was obtained within
an experimental context in which our research team was
investigating the electron microscopy effects induced by
methamphetamine. This is a powerful drug of abuse and also a
neurotoxin which dramatically alters the ATG pathway (Larsen
et al., 2002; Fornai et al., 2004; Castino et al., 2008; Pasquali
et al., 2008). In fact, methamphetamine produces a massive
accumulation of giant aberrant ATG vacuoles (Fornai et al.,
2004). In the recent data reported here for the first time the
experimental conditions are just opposite since in GBM cell lines
ATG is depressed. Nonetheless, the presence of autophagosome
was still noticeable. Conversely, in PC12 ATG is upregulated
and baseline levels of autophagosomes are elevated (Fornai
et al., 2007). This is further augmented by methamphetamine
exposure (Fornai et al., 2004, 2007; Lazzeri et al., 2007). Thus,
it is not surprising that the density of autophagoproteasome we
measured here in PC12 in baseline conditions is two-fold the
density we measured in U87MG. In any case, even in U87MG
cells where ATG is suppressed, the autophagoproteasome is
detectable and it increases dramatically by blocking mTOR
with rapamycin. This produces a concomitant increase in
autophagosomes and autophagoproteasomes. As reported in the
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FIGURE 13 | Convergency between UP and ATG. The simplified cartoon reports the main clearing pathways of eukaryotic cells emphasizing the significance of
the autophagoproteasome which is the focus of the present manuscript. This organelle is likely to play a pivotal role in those disorders which are characterized by
accumulation of misfolded proteins and altered mitochondria. The significance of this novel anatomical entity for neurological disorders is likely to be enormous since
a growing body of neuropathological and pathobiochemical data demonstrate a failure of clearing pathways as key in both acute and chronic neurodegenerative
conditions. These include cerebrovascular disorders and epilepsy (Natale et al., 2011; Orzi et al., 2013; Giorgi et al., 2015). In these disorders a defective ATG or UP
are more and more evident (Ge et al., 2012; Caldeira et al., 2014; Fang et al., 2015; Giorgi et al., 2015; Wu et al., 2015). In fact, each step of the UP and/or ATG
cascade may be affected either by toxic exposure or genetic mutations. Thus, providing the evidence for a further and ultimate organelle is expected to uncover a
variety of disease causes and molecular mechanisms to be deciphered in clinical neuroanatomy. The site-specificity of the occurrence of autophagoproteasomes
within different brain areas, and within each area between different neuronal cell type calls for in depth investigations aimed at disclosing the intrinsic vulnerability
(Continued)
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FIGURE 13 | Continued
which may characterize various neural population in the presence of
autophagoproteasome failure. In baseline conditions autophagoproteasome
does occur. This is true also for extremely detrimental conditions for ATG
machinery just like those reported in baseline conditions in the present
manuscript. In fact, U87MG cells possess a dramatic upregulation of mTOR
which in turn suppresses ATG. It seems that this produces an inhibition of
both ATG and UP machinery leading a synergistic suppression of
autophagoproteasome. This evidence confirms what recently postulated
based on functional studies on the dual regulation of UP and ATG by mTOR
(Zhao et al., 2015). Nowadays, owing an improved knowledge of a parallelism
between these clearing pathways we are allowed to face the problem as a
unified matter where the convergence of both pathways is expected to be
dramatically occluded by mTOR inhibition. Nonetheless, even when mTOR is
overactive we observed that, in line with the cartoon, the
autophagoproteasome “may be derived from the fusion of
ubiquitin-proteasome with either early or late autophagosome containing
cytosolic material at various stages of degradation” (Klionsky et al., 2016). This
adds on enzymatic activity of amphisome thus leading to the most powerful
clearing system potentially described in eukaryotic cells so far.
cartoon of Figure 13, ‘‘the autophagoproteasome may be derived
from the inclusion of ubiquitin-proteasome structures within
either early or late autophagosomes containing cytoplasmic
material at various stages of degradation’’ (Klionsky et al., 2016),
which adds on enzymatic activity of amphisome which leads
to the most powerful clearing system described in eukaryotic
cells so far. Assuming that the thickness of the ultrathin slide
allows to visualize a small part of the whole volume of each
vacuole which is stained by small particles, we assume that
the amount of autophagoproteasomes in the cell reported here
is way underestimated. For the same reason, it is likely that
all vacuoles described here contains LC3 since these particles
were evident in roughly 50% of the sections. At the same
time, the occurrence of P20S, which is likely to be more
scattered was detected in 12% of the vacuole areas. If we assume
that each ATG vacuole is indeed an autophagoproteasome
than we would expect that the amount of vacuoles containing
both LC3 and P20S in the same ultrathin section corresponds
to the combination of the chances to visualize either LC3
or P20S. In fact, this chance roughly corresponds to the
number of double stained vacuoles we counted. Remarkably,
the ratio between the number of clearance hallmarks (LC3
and P20S) and the number of vacuoles remains steady for
the whole range of ATG activation. This suggests that, when
ATG is occluded the ambiguous nature of the vacuoles (both
ATG and UP organelles) is not substantially modified. This
will be consistent with the hypothesis that ATG stimulation
necessarily implies proteasome activation and vice versa, in
contrast ATG inhibition (or UP inhibition) is expected to
occlude both phenomena, at the same time for the same
magnitude. Recent functional evidence on this point provides
contrasting data (Korolchuk et al., 2009; Wang et al., 2013;
Tian et al., 2014; Zhang et al., 2015; Zhao et al., 2015). This
may depend on the slight shifting we documented here between
mild and strong mTOR inhibition which produces a slight
prevalence of ATG over UP or vice versa, respectively. In
line with this hypothesis one may speculate that the pivotal
molecular complex for ATG regulation, mTOR, is pivotal
for UP regulation as well, but fine modulation is critical.
This experimental issue is presently under scrutiny in our
laboratory.
CONCLUSION
In the present manuscript evidence is provided that ATG and
UP components are placed in a novel organelle, which is now
detailed at morphological level. This is the site where a functional
interaction between ATG components and UP takes place to
terminate substrate degradation as very recently postulated by
Liu and Chen (2016).
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